======= TBL1XR1 ======= == Gene Information == * **Official Symbol**: TBL1XR1 * **Official Name**: TBL1X receptor 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79718|79718]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BZK7|Q9BZK7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TBL1XR1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBL1XR1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608628|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of the WD40 repeat-containing gene family and shares sequence similarity with transducin (beta)-like 1X-linked (TBL1X). The protein encoded by this gene is thought to be a component of both nuclear receptor corepressor (N-CoR) and histone deacetylase 3 (HDAC 3) complexes, and is required for transcriptional activation by a variety of transcription factors. Mutations in these gene have been associated with some autism spectrum disorders, and one finding suggests that haploinsufficiency of this gene may be a cause of intellectual disability with dysmorphism. Mutations in this gene as well as recurrent translocations involving this gene have also been observed in some tumors. [provided by RefSeq, Mar 2016]. * **UniProt Summary**: F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation. {ECO:0000269|PubMed:14980219}. |LisH| |WD40| |fat pad development| |white fat cell differentiation| |blastocyst hatching| |hatching| |organism emergence from protective structure| |response to dietary excess| |regulation of triglyceride metabolic process| |adipose tissue development| |histone deacetylase complex| |histone deacetylation| |protein deacetylation| |transcriptional repressor complex| |protein deacylation| |macromolecule deacylation| |mitotic spindle| |multicellular organism growth| |beta-catenin binding| |blastocyst development| |fat cell differentiation| |protein N-terminus binding| |histone binding| |positive regulation of canonical Wnt signaling pathway| |positive regulation of Wnt signaling pathway| |transcription regulatory region DNA binding| |connective tissue development| |transcription corepressor activity| |regulation of canonical Wnt signaling pathway| |lipid catabolic process| |proteasome-mediated ubiquitin-dependent protein catabolic process| |proteasomal protein catabolic process| |regulation of Wnt signaling pathway| |histone modification| |covalent chromatin modification| |in utero embryonic development| |developmental growth| |growth| |regulation of lipid metabolic process| |response to nutrient levels| |ubiquitin-dependent protein catabolic process| |response to extracellular stimulus| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |chordate embryonic development| |embryo development ending in birth or egg hatching| |protein catabolic process| |chromatin organization| |negative regulation of transcription by RNA polymerase II| |cellular macromolecule catabolic process| |embryo development| |macromolecule catabolic process| |organonitrogen compound catabolic process| |chromosome organization| |negative regulation of transcription, DNA-templated| |lipid metabolic process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |proteolysis| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |organic substance catabolic process| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp241|QNZ 0.01μM R05 exp241]]|-2.09| |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|-2.06| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-1.94| |[[:results:exp275|Citral 75μM R06 exp275]]|-1.77| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.76| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-1.71| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|1.91| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|2| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.32| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 22/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|0/28| |bone|1/25| |breast|2/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|3/75| |lymphocyte|3/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|2/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 19057 * **Expression level (log2 read counts)**: 7.74 {{:chemogenomics:nalm6 dist.png?nolink |}}